{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:17:19Z","timestamp":1785417439760,"version":"3.56.0"},"posted":{"date-parts":[[2026,6,24]]},"group-title":"Surgery","reference-count":31,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["T32DK007673"],"award-info":[{"award-number":["T32DK007673"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"https:\/\/ror.org\/04pw6fb54","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Lynch Regenerative Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A drug-repurposing-specific phenome-wide association study (PheWAS) demonstrated that patients with a single nucleotide variant that decreases expression of platelet-derived growth factor receptor beta (PDGFR\u03b2) have a higher prevalence of fistulas, suggesting that PDGFR\u03b2 signaling is important for tissue repair. Recombinant human platelet derived growth factor B (rhPDGF) is an FDA-approved protein-based therapeutic that signals through PDGFR\u03b2 to heal and regenerate cutaneous skin wounds, periodontal tissue, and orthopedic bone with a strong safety profile. We hypothesize that rhPDGF will benefit other conditions identified by PheWAS with a similar physiological mechanism as the existing indications, such as complex perianal fistulas that are ineligible for a fistulotomy.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This prospective, blinded, single-site study aims to enroll 12 participants, randomized at a ratio of 2:1, comparing implantation of rhPDGF-enhanced collagen to routine care procedures, and stratified by fistula etiology, idiopathic versus Crohn\u2019s disease (CD)-related. The primary outcome of this study will evaluate the technical performance of the rhPDGF-enhanced collagen implant for treatment of complex perianal fistulas as measured by the proportion of participants with successful implantation of the intervention without any intervention-related serious adverse events. The secondary outcomes will assess the preliminary safety and efficacy of the intervention based on all intervention-related adverse events, total fistulas healed, rate of fistula recurrence, and change in patient-reported symptoms. Complex perianal fistulas, idiopathic or CD-related, remain a major clinical challenge in need of new multimodal treatments aimed at tissue repair and regeneration. Pharmaceutical rhPDGF stimulation of PDGFR\u03b2 signaling promotes healing of skin, bone, and soft tissue. PheWAS revealed fistulas as a novel indication for repurposing rhPDGF. This protocol aims to evaluate the technical performance, preliminary safety and efficacy, and feasibility of rhPDGF-enhanced collagen for healing and remission of complex perianal fistulas.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>This trial was approved by the Vanderbilt University Medical Center institutional review board (IRB#240585). Results will be submitted for publication in a peer-reviewed journal.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Clinical trial registration<\/jats:title>\n                  <jats:p>\n                    This trial is registered at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                    (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06632418\">NCT06632418<\/jats:ext-link>\n                    ).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>STRENGTHS AND LIMITATIONS OF THIS STUDY<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>In this trial we utilized a novel drug repurposing approach, PheWAS, to identify fistulas as a novel pathophysiological phenotype which may benefit from a pharmacological intervention targeting the PDGF signaling pathway.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>A crossover design was employed to improve recruitment and retention, allowing patients within the control group the opportunity to receive the intervention if their fistula fails to heal.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Our secondary outcomes will include stratified subgroup analyses for idiopathic and CD-related fistulas allowing us to determine if PDGF may benefit one fistula etiology over the other.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Due to the complexity of perianal fistula etiology, stringent exclusion criteria were required to establish a study population who might benefit the most and the small sample size restricts the ability to perform subgroup analyses and limits statistical power for efficacy outcomes.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>The control procedures differ based on disease etiology (idiopathic vs CD-related) yet all patients undergoing treatment receive the same procedure, as such, the interpretation of the secondary outcomes may be difficult due to the lack of a true placebo.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.22.26356267","type":"posted-content","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:40:28Z","timestamp":1782355228000},"source":"Crossref","is-referenced-by-count":0,"title":["Study protocol and statistical analysis plan for a randomized controlled trial evaluating the safety and feasibility of the recombinant human platelet-derived growth factor B (rhPDGF-BB)-enhanced collagen plug for complex perianal fistula healing"],"prefix":"10.64898","author":[{"given":"Marissa C","family":"Kuo","sequence":"first","affiliation":[{"name":"Division of General Surgery, Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A","family":"Younan","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D","family":"Lempicki","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex T","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Smith","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana K","family":"Shirey-Rice","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M","family":"Pulley","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E","family":"Lynch","sequence":"additional","affiliation":[{"name":"Lynch Regenerative Medicine, Franklin, Tennessee, United States of America"},{"name":"Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"},{"name":"Harvard School of Dental Medicine, Boston, Massachusetts, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E","family":"Ueland","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimal","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of General Surgery, Section of Colon & Rectal Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndi R","family":"Clark","sequence":"additional","affiliation":[{"name":"Vanderbilt Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan S","family":"Blette","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026062700100757000_2026.06.22.26356267v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa870"},{"key":"2026062700100757000_2026.06.22.26356267v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2749"},{"key":"2026062700100757000_2026.06.22.26356267v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq126"},{"key":"2026062700100757000_2026.06.22.26356267v1.4","unstructured":"Plastic and Reconstructive Surgery [Internet]. [cited 2026 Jan 8]. Available from: https:\/\/journals.lww.com\/plasreconsurg\/abstract\/9900\/_pure_recombinant_platelet_derived_growth_factor.2779.aspx"},{"issue":"2","key":"2026062700100757000_2026.06.22.26356267v1.5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000512652","article-title":"Surgical Management of Idiopathic Perianal Fistulas: A Systematic Review and Meta-Analysis","volume":"38","year":"2021","journal-title":"Dig Surg"},{"key":"2026062700100757000_2026.06.22.26356267v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-30902-2_1-1"},{"issue":"3","key":"2026062700100757000_2026.06.22.26356267v1.7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/DCR.0000000000001271","article-title":"Persistent Fistula After Anorectal Abscess Drainage: Local Experience of 11 Years","volume":"62","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"2026062700100757000_2026.06.22.26356267v1.8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/DCR.0000000000000733","article-title":"Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula","volume":"59","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"2026062700100757000_2026.06.22.26356267v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800820112"},{"issue":"3","key":"2026062700100757000_2026.06.22.26356267v1.10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/codi.12810","article-title":"What role do bacteria play in persisting fistula formation in idiopathic and Crohn\u2019s anal fistula?","volume":"17","year":"2015","journal-title":"Colorectal Dis"},{"issue":"6","key":"2026062700100757000_2026.06.22.26356267v1.11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10151-017-1645-5","article-title":"Pathogenesis and persistence of cryptoglandular anal fistula: a systematic review","volume":"21","year":"2017","journal-title":"Tech Coloproctology"},{"key":"2026062700100757000_2026.06.22.26356267v1.12","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v10.i4.42"},{"issue":"2","key":"2026062700100757000_2026.06.22.26356267v1.13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn\u2019s disease","volume":"64","year":"2018","journal-title":"Dis--Mon DM"},{"key":"2026062700100757000_2026.06.22.26356267v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab287"},{"issue":"5","key":"2026062700100757000_2026.06.22.26356267v1.15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3748\/wjg.v21.i5.1394","article-title":"Management of perianal fistulas in Crohn\u2019s disease: An up-to-date review","volume":"21","year":"2015","journal-title":"World J Gastroenterol WJG"},{"key":"2026062700100757000_2026.06.22.26356267v1.16","unstructured":"Understanding the anatomical basis of anorectal fistulas and their surgical management: exploring different types for enhanced precision and safety | Surgery Today [Internet]. [cited 2025 Dec 30]. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00595-025-02995-2"},{"issue":"11","key":"2026062700100757000_2026.06.22.26356267v1.17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/DCR.0000000000000216","article-title":"Outcomes after operations for anal fistula: results of a prospective, multicenter, regional study","volume":"57","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"2026062700100757000_2026.06.22.26356267v1.18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/bjs5.13","article-title":"Systematic review of surgical interventions for Crohn\u2019s anal fistula","volume":"1","year":"2017","journal-title":"BJS Open"},{"key":"2026062700100757000_2026.06.22.26356267v1.19","first-page":"e928181","article-title":"Long-Term Clinical Results of Use of an Anal Fistula Plug for Treatment of Low Trans-Sphincteric Anal Fistulas","volume":"26","year":"2020","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"10","key":"2026062700100757000_2026.06.22.26356267v1.20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00383-010-2664-8","article-title":"Usefulness of bFGF spray in the treatment of perianal abscess and fistula-in-ano","volume":"26","year":"2010","journal-title":"Pediatr Surg Int"},{"issue":"10","key":"2026062700100757000_2026.06.22.26356267v1.21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/DCR.0000000000001924","article-title":"Efficacy and Safety of Treatment of Complex Idiopathic Fistula-in-Ano Using Autologous Centrifuged Adipose Tissue Containing Progenitor Cells: A Randomized Controlled Trial","volume":"64","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"2026062700100757000_2026.06.22.26356267v1.22","first-page":"e608","article-title":"Alternative method to treat oroantral communication and fistula with autogenous bone graft and platelet rich firbin","volume":"21","year":"2016","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"2026062700100757000_2026.06.22.26356267v1.23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/15533506221086778","article-title":"Minimally Invasive Treatment of Recurrent Anal Fistulas with Autologous Platelet-Rich Plasma Combined With Internal Orifice Closure","volume":"30","year":"2023","journal-title":"Surg Innov"},{"key":"2026062700100757000_2026.06.22.26356267v1.24","doi-asserted-by":"crossref","first-page":"7660118","DOI":"10.1155\/2022\/7660118","article-title":"Autologous Bioactive Compound Concentrated Growth Factor Ameliorates Fistula Healing of Anal Fistula in a Pig Model and Promotes Proliferation and Migration of Human Skin Fibroblasts via Regulating the MEK\/ERK Pathway","volume":"2022","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"2026062700100757000_2026.06.22.26356267v1.25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10151-015-1311-8","article-title":"Treatment of Crohn\u2019s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study","volume":"19","year":"2015","journal-title":"Tech Coloproctology"},{"key":"2026062700100757000_2026.06.22.26356267v1.26","unstructured":"Futyma K. Platelet Rich Plasma as adjuvant therapy for recurrent Vesico-Vaginal Fistula - report after first 10 cases [Internet]. 2019 Sept 4 [cited 2023 Nov 27]; Lublin, Poland. Available from: https:\/\/www.ics.org\/2019\/abstract\/111"},{"key":"2026062700100757000_2026.06.22.26356267v1.27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejogrb.2022.05.017","article-title":"Does freeze dried amnion useful as scaffold for mesenchymal stem cell for repair of vesicovaginal fistula? An overview of proliferative and remodeling phase in the wound healing process","volume":"274","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2026062700100757000_2026.06.22.26356267v1.28","first-page":"345","article-title":"Use of autologous platelet rich fibrin in urethracutaneous fistula repair: preliminary report","volume":"10","year":"2012","journal-title":"Int Wound J"},{"key":"2026062700100757000_2026.06.22.26356267v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<1::AID-SIM134>3.0.CO;2-E"},{"key":"2026062700100757000_2026.06.22.26356267v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20182"},{"key":"2026062700100757000_2026.06.22.26356267v1.31","unstructured":"Charalampopoulos A , Papakonstantinou D , Bagias G , Nastos K , Perdikaris M , Papagrigoriadis S . Surgery of Simple and Complex Anal Fistulae in Adults: A Review of the Literature for Optimal Surgical Outcomes. Cureus. 15(3):e35888."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.22.26356267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:10:18Z","timestamp":1782544218000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.06.22.26356267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":31,"URL":"https:\/\/doi.org\/10.64898\/2026.06.22.26356267","relation":{},"subject":[],"published":{"date-parts":[[2026,6,24]]},"subtype":"preprint"}}